STEELE GLENN JR MD PHD sold PTCT
January 2, 2026 · Form 4 insider transaction
STEELE GLENN JR MD PHD sold 12,000 shares of PTC Therapeutics, Inc. at $76.35 per share, a transaction worth $916.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,000
Price
$76.35
Total value
$916.2K
InsiderSTEELE GLENN JR MD PHD
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after18,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 8, 2025.